Comparative Study on the Therapeutic Outcomes of Enzalutamide Combined with Docetaxel Versus Docetaxel Alone in Metastatic Castration-Resistant Prostate Cancer Patients Following Sequential Androgen Receptor Pathway Targeted Therapy Failure
收藏Figshare2025-04-02 更新2026-04-08 收录
下载链接：
https://figshare.com/articles/dataset/Comparative_Study_on_the_Therapeutic_Outcomes_of_Enzalutamide_Combined_with_Docetaxel_Versus_Docetaxel_Alone_in_Metastatic_Castration-Resistant_Prostate_Cancer_Patients_Following_Sequential_Androgen_Receptor_Pathway_Targeted_Therapy_Failure/28716245/1
下载链接
链接失效反馈官方服务：
资源简介：
To evaluate the therapeutic effectiveness and adverse effects of combining enzalutamide with docetaxel versus using docetaxel alone in treating metastatic castration-resistant prostate cancer (mCRPC) that progresses after effective treatment with abiraterone followed by enzalutamide.
提供机构：
Zhang, Zhiyu
创建时间：
2025-04-02
